Cannabinoid tetrad

Record Type: Evaluation

Validation: GLP, Non-GLP

Disease: CNS

The cannabinoid tetrad test screens pharmacological compounds that induce cannabinoid receptor-mediated effects. This preclinical model includes a series of four tests, i.e., behavioral components, which are spontaneous activity, catalepsy, hypothermia and analgesia.

Industry Market

Pharma

Phase

Nonclinical